AVBP ArriVent BioPharma, Inc. - Common Stock
$29,97
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$17–$36
69% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$45
+49% upside
P/E (TTM)
-6.9
ROE
-59.7%
Nettogewinnmarge
—
AVBP Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$29.97
Marktkapitalisierung
$1.27B
P/E (TTM)
-6.9
EPS (TTM)
$-4.32
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-59.7%
Verschuldungsgrad
—
52W-Spanne
$17 – $36
AVBP Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-4.32
2023-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
AVBP
Peer-Median
P/E (TTM)
-6.9
—
P/B (K/B)
4.1
2.7
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
AVBP
Peer-Median
ROA
-54.7%
-43.1%
ROE
-59.7%
-49.0%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
AVBP
Peer-Median
Current Ratio (Liquiditätsgrad)
12.8
9.0
Quick Ratio
12.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
AVBP
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
AVBP
Peer-Median
AVBP Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 7 38,9%
- Kauf 10 55,6%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-19
Median
$45.00
← Unter allen Zielen
$29.97
Tief
$40.00
Hoch
$50.00
Median-Ziel
$45.00
+50,2%
Mittelwert-Ziel
$44.70
+49,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.28%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.96 | $-0.91 | -0.05% |
| 31. Dezember 2025 | $-0.78 | $-0.86 | 0.08% |
| 30. September 2025 | $-0.83 | $-0.81 | -0.02% |
| 30. Juni 2025 | $-0.90 | $-0.72 | -0.18% |
| 31. März 2025 | $-1.90 | $-0.68 | -1.2% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| AKTS | — | — | — | — | — | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| PURR | — | — | — | — | — | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $153M | $79M | $65M | |
| SG&A Expense | $24M | $15M | $10M | |
| Operating Expenses | $178M | $94M | $75M | |
| Operating Income | $-178M | $-94M | $-75M | |
| Net Income | $-166M | $-80M | $-69M | |
| EPS (Basic) | $-4.32 | $-2.56 | $-32.38 | |
| EPS (Diluted) | $-4.32 | $-2.56 | $-32.38 | |
| Shares (Basic) | 38,462,600 | 31,469,328 | 2,140,951 | |
| Shares (Diluted) | 38,462,600 | 31,469,328 | 2,140,951 | |
| EBITDA | $-181M | $-94M | · |
Bilanz 18
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $46M | $74M | $150M | |
| Short-term Investments | $267M | $145M | · | |
| Prepaid Expense | $20M | $8M | $10M | |
| Current Assets | $333M | $227M | $160M | |
| Other Non-current Assets | $190.0K | $126.0K | $107.0K | |
| Total Assets | $333M | $275M | $163M | |
| Accounts Payable | $6M | $4M | $5M | |
| Accrued Liabilities | $20M | $13M | $7M | |
| Current Liabilities | $26M | $17M | $12M | |
| Capital Leases | · | $14.0K | $177.0K | |
| Total Liabilities | $26M | $17M | $12M | |
| Common Stock | $4.0K | $3.0K | · | |
| Paid-in Capital | $712M | $496M | $5M | |
| Retained Earnings | $-405M | $-238M | $-158M | |
| AOCI | $14.0K | $-211.0K | · | |
| Stockholders' Equity | $307M | $258M | $-153M | |
| Liabilities + Equity | $333M | $275M | $163M | |
| Shares Outstanding | 42,452,251 | 33,706,765 | 2,745,480 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $-3M | · | · | |
| Stock-based Comp | $13M | $3M | $895.0K | |
| Other Non-cash | $-4M | · | · | |
| Operating Cash Flow | $-161M | $-70M | $-56M | |
| Investing Cash Flow | $-71M | $-192M | · | |
| Stock Issued | $203M | $186M | · | |
| Net Stock Activity | $203M | · | · | |
| Financing Cash Flow | $203M | $187M | $43M | |
| Net Change in Cash | $-29M | $-76M | $-13M | |
| Taxes Paid | $0 | · | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -54.7% | -36.8% | · | |
| ROE | -59.7% | -30.1% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.8 | 13.1 | · | |
| Quick Ratio | 12.1 | 12.7 | · |
Bewertung (TTM) 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-166M | $-80M | $-69M | |
| Market Cap | $854M | $898M | · | |
| P/E | -4.7 | -10.4 | · | |
| P/B | 2.8 | 3.5 | · | |
| P / Tangible Book | 2.8 | 3.5 | · | |
| P / Cash Flow | -5.3 | -12.8 | · | |
| Earnings Yield | -21.5% | -9.6% | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $42M | $38M | $32M | $32M | $28M | $61M | $20M | $20M | $22M | $17M | $20M | |
| SG&A Expense | $10M | $8M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $53M | $46M | $39M | $38M | $34M | $67M | $24M | $24M | $26M | $21M | $23M | |
| Operating Income | $-53M | $-46M | $-39M | $-38M | $-34M | $-67M | $-24M | $-24M | $-26M | $-21M | $-23M | |
| Interest Income | · | · | · | · | · | · | · | $4M | $4M | $3M | · | |
| Net Income | $-50M | $-43M | $-36M | $-35M | $-31M | $-64M | $-21M | $-21M | $-22M | $-17M | $-21M | |
| EPS (Basic) | $-1.05 | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | |
| EPS (Diluted) | $-1.05 | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | |
| Shares (Basic) | 47,606,857 | 45,067,658 | -72,355,289 | 41,912,905 | 35,006,114 | 33,898,870 | -60,661,360 | 33,581,810 | 33,502,347 | 25,046,531 | -3,753,520 | |
| Shares (Diluted) | 47,606,857 | 45,067,658 | -72,355,289 | 41,912,905 | 35,006,114 | 33,898,870 | -60,661,360 | 33,581,810 | 33,502,347 | 25,046,531 | -3,753,520 | |
| EBITDA | $-53M | $-47M | · | $-38M | $-34M | $-67M | · | $-24M | $-26M | $-21M | · |
Bilanz 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $62M | $46M | $113M | $113M | $50M | $74M | $283M | $299M | $317M | $150M | |
| Short-term Investments | $218M | $264M | $267M | $188M | $123M | $126M | $145M | · | · | · | · | |
| Prepaid Expense | $21M | $22M | $20M | $21M | $14M | $10M | $8M | $10M | $10M | $10M | $10M | |
| Current Assets | $394M | $349M | $333M | $321M | $250M | $186M | $227M | $292M | $309M | $327M | $160M | |
| Other Non-current Assets | $134.0K | $156.0K | $190.0K | $180.0K | $479.0K | $176.0K | $126.0K | $126.0K | $125.0K | $108.0K | $107.0K | |
| Total Assets | $395M | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | |
| Accounts Payable | $2M | $9M | $6M | $6M | $4M | $4M | $4M | $5M | $4M | $4M | $5M | |
| Accrued Liabilities | $25M | $16M | $20M | $16M | $15M | $8M | $13M | $10M | $8M | $6M | $7M | |
| Current Liabilities | $28M | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | |
| Capital Leases | $33.0K | $320.0K | · | · | · | · | $14.0K | $56.0K | $98.0K | $138.0K | $177.0K | |
| Total Liabilities | $28M | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | |
| Paid-in Capital | $865M | $772M | $712M | $674M | $584M | $505M | $496M | $495M | $494M | $493M | $5M | |
| Retained Earnings | $-498M | $-448M | $-405M | $-369M | $-334M | $-303M | $-238M | $-218M | $-197M | $-175M | $-158M | |
| AOCI | $-267.0K | $-270.0K | $14.0K | $206.0K | $-18.0K | $-17.0K | $-211.0K | · | · | · | · | |
| Stockholders' Equity | $367M | $324M | $307M | $305M | $250M | $203M | $258M | $277M | $297M | $318M | $-153M | |
| Liabilities + Equity | $395M | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | |
| Shares Outstanding | 48,319,591 | 45,308,941 | 42,452,251 | 40,852,312 | 37,490,439 | 34,040,996 | 33,706,765 | 33,694,355 | 33,509,090 | 33,493,750 | 2,745,480 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-515.0K | $-559.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $7M | $5M | $3M | $4M | $3M | $2M | $952.0K | $866.0K | $765.0K | $625.0K | $319.0K | |
| Other Non-cash | · | $-3M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-40M | $-42M | $-31M | $-36M | $-26M | $-68M | $-16M | $-16M | $-19M | $-19M | $-15M | |
| Investing Cash Flow | $46M | $4M | $-71M | $-51M | $14M | $37M | · | · | · | · | · | |
| Stock Issued | $85M | $55M | $35M | $86M | $75M | $7M | $0 | · | · | $186M | · | |
| Net Stock Activity | · | $55M | · | · | · | · | · | · | · | $186M | · | |
| Financing Cash Flow | $86M | $55M | $35M | $86M | $75M | $7M | $55.0K | $531.0K | $363.0K | $186M | $-1M | |
| Net Change in Cash | $93M | $17M | $-67M | $-93.0K | $63M | $-24M | $-209M | $-16M | $-19M | $167M | $9M |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -15.3% | · | -11.3% | -10.9% | -23.7% | · | -14.1% | -14.2% | -10.6% | · | |
| ROE | -16.2% | -16.5% | · | -12.0% | -11.5% | -24.8% | · | -14.8% | -14.8% | -11.0% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 14.0 | · | 14.9 | 12.7 | 14.3 | · | 19.3 | 25.5 | 32.8 | · | |
| Quick Ratio | 13.4 | 13.1 | · | 13.9 | 12.0 | 13.6 | · | 18.7 | 24.7 | 31.8 | · |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-160M | $-174M | · | $-151M | $-138M | $-124M | · | $-74M | $-75M | $-66M | · | |
| Market Cap | $1.68B | $1.05B | · | $754M | $816M | $629M | · | $792M | $622M | $598M | · | |
| P/E | -9.3 | -5.0 | · | -4.4 | -5.4 | -4.8 | · | -3.1 | -1.1 | -0.7 | · | |
| P/B | 4.6 | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | |
| P / Tangible Book | 4.6 | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | |
| P / Cash Flow | · | -25.0 | · | · | · | -9.3 | · | · | · | -32.1 | · | |
| Earnings Yield | -10.8% | -19.9% | · | -23.0% | -18.6% | -20.9% | · | -31.8% | -95.2% | -148.2% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Nettoergebnis | $-166M | $-80M | $-69M |
| Verwässerte EPS | $-4.32 | $-2.56 | $-32.38 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 12.8 | 13.1 | — |
| Quick Ratio | 12.1 | 12.7 | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 169 Einreicher · $1.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (+4 vs. Vorquartal) | 13 (-2 vs. Vorquartal) | 64 (+9 vs. Vorquartal) | 36 (+10 vs. Vorquartal) | +5.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $156.869.547 | 4.515.531 | 10,85% | Aktien |
| INFINITUM ASSET MANAGEMENT, LLC | $154.189.460 | 4.438.384 | 10,66% | Aktien |
| HHLR ADVISORS, LTD. | $136.497.525 | 3.929.117 | 9,44% | Aktien |
| ORBIMED ADVISORS LLC | $105.169.375 | 3.027.328 | 7,27% | Aktien |
| FMR LLC | $80.933.813 | 2.329.701 | 5,60% | Aktien |
| Octagon Capital Advisors LP | $68.474.416 | 1.971.054 | 4,73% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $61.659.088 | 1.774.873 | 4,26% | Aktien |
| Sofinnova Investments, Inc. | $58.945.164 | 1.696.752 | 4,08% | Aktien |
| STATE STREET CORP | $58.814.334 | 1.692.986 | 4,07% | Aktien |
| Vivo Capital, LLC | $58.436.050 | 1.682.097 | 4,04% | Aktien |
| NOVO HOLDINGS A/S | $52.110.000 | 1.500.000 | 3,60% | Aktien |
| General Catalyst Group Management, LLC | $51.928.866 | 1.494.786 | 3,59% | Aktien |
| Logos Global Management LP | $34.740.000 | 1.000.000 | 2,40% | Aktien |
| D. E. Shaw & Co., Inc. | $30.293.662 | 872.011 | 2,09% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $29.105.185 | 837.610 | 2,01% | Aktien |
| HSG Holding Ltd | $23.043.320 | 663.308 | 1,59% | Aktien |
| Point72 Asset Management, L.P. | $19.690.493 | 566.796 | 1,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $18.414.701 | 530.072 | 1,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $17.658.342 | 508.300 | 1,22% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $15.239.187 | 438.664 | 1,05% | Aktien |
| UBS Group AG | $15.236.756 | 438.594 | 1,05% | Aktien |
| Balyasny Asset Management L.P. | $13.737.829 | 395.447 | 0,95% | Aktien |
| AMERIPRISE FINANCIAL INC | $13.256.401 | 381.589 | 0,92% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11.649.017 | 335.320 | 0,81% | Aktien |
| Foresite Capital Management VI LLC | $10.468.586 | 301.341 | 0,72% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.221.342 | 294.224 | 0,71% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $9.007.735 | 259.290 | 0,62% | Aktien |
| Seven Fleet Capital Management LP | $8.567.092 | 246.606 | 0,59% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $7.597.430 | 218.694 | 0,53% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $6.676.160 | 192.175 | 0,46% | Aktien |
| Squadron Capital Management LLC | $6.357.420 | 183.000 | 0,44% | Kaufoption |
| CITADEL ADVISORS LLC | $5.445.217 | 156.742 | 0,38% | Aktien |
| NOMURA HOLDINGS INC | $5.371.395 | 154.617 | 0,37% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.210.305 | 149.980 | 0,36% | Aktien |
| Woodline Partners LP | $5.128.979 | 147.639 | 0,35% | Aktien |
| JANE STREET GROUP, LLC | $4.811.490 | 138.500 | 0,33% | Kaufoption |
| Affinity Asset Advisors, LLC | $4.342.500 | 125.000 | 0,30% | Aktien |
| E Fund Management Co., Ltd. | $3.798.055 | 109.328 | 0,26% | Aktien |
| KVP Capital Advisors, LP | $3.543.480 | 102.000 | 0,24% | Aktien |
| Burkehill Global Management, LP | $3.474.000 | 100.000 | 0,24% | Aktien |
| CITADEL ADVISORS LLC | $2.834.784 | 81.600 | 0,20% | Kaufoption |
| SECTORAL ASSET MANAGEMENT INC | $2.745.954 | 79.043 | 0,19% | Aktien |
| Trexquant Investment LP | $2.496.416 | 71.860 | 0,17% | Aktien |
| BARCLAYS PLC | $2.362.910 | 68.017 | 0,16% | Aktien |
| XTX Topco Ltd | $2.165.414 | 62.332 | 0,15% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.008.111 | 57.804 | 0,14% | Aktien |
| Soleus Capital Management, L.P. | $1.737.000 | 50.000 | 0,12% | Aktien |
| Quadrature Capital Ltd | $1.706.603 | 49.125 | 0,12% | Aktien |
| Swiss National Bank | $1.695.312 | 48.800 | 0,12% | Aktien |
| ALPS ADVISORS INC | $1.635.351 | 47.074 | 0,11% | Aktien |
| BlackRock, Inc. | $1.621.628 | 46.679 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $1.606.853 | 46.254 | 0,11% | Aktien |
| Moody Aldrich Partners LLC | $1.530.089 | 44.044 | 0,11% | Aktien |
| CITIGROUP INC | $1.357.535 | 39.077 | 0,09% | Aktien |
| Quantinno Capital Management LP | $1.273.256 | 36.651 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $1.225.905 | 35.288 | 0,08% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.112.583 | 32.026 | 0,08% | Aktien |
| Jump Financial, LLC | $1.029.833 | 29.644 | 0,07% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.004.929 | 43.560 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $992.939 | 28.582 | 0,07% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $982.551 | 28.283 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $976.194 | 28.100 | 0,07% | Verkaufsoption |
| Ellsworth Advisors, LLC | $889.683 | 27.001 | 0,06% | Aktien |
| Rafferty Asset Management, LLC | $846.961 | 24.380 | 0,06% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $808.990 | 23.287 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $776.786 | 22.360 | 0,05% | Aktien |
| Engineers Gate Manager LP | $773.278 | 22.259 | 0,05% | Aktien |
| TWO SIGMA ADVISERS, LP | $746.452 | 37.100 | 0,05% | Aktien |
| Corient Private Wealth LP | $708.072 | 20.382 | 0,05% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $678.611 | 19.534 | 0,05% | Aktien |
| JPMORGAN CHASE & CO | $661.863 | 19.257 | 0,05% | Aktien |
| TEMA ETFS LLC | $643.981 | 32.007 | 0,04% | Aktien |
| Squarepoint Ops LLC | $609.479 | 17.544 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $606.630 | 17.462 | 0,04% | Aktien |
| Caption Management, LLC | $554.694 | 15.967 | 0,04% | Aktien |
| Persistent Asset Partners Ltd | $546.599 | 15.734 | 0,04% | Aktien |
| Invesco Ltd. | $520.370 | 14.979 | 0,04% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $517.383 | 14.893 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $513.561 | 14.783 | 0,04% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446.797 | 19.367 | 0,03% | Aktien |
| PROFUND ADVISORS LLC | $439.218 | 12.643 | 0,03% | Aktien |
| Optimize Financial Inc | $436.392 | 18.916 | 0,03% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $413.337 | 11.898 | 0,03% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $411.426 | 11.843 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $406.597 | 11.704 | 0,03% | Aktien |
| Jain Global LLC | $399.058 | 11.487 | 0,03% | Aktien |
| DeepCurrents Investment Group LLC | $390.026 | 11.227 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $388.532 | 11.184 | 0,03% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $388.046 | 11.170 | 0,03% | Aktien |
| Virtus Investment Advisers, LLC | $372.204 | 10.714 | 0,03% | Aktien |
| Aquatic Capital Management LLC | $368.175 | 10.598 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $360.011 | 10.363 | 0,02% | Aktien |
| GLENMEDE TRUST CO NA | $346.357 | 9.970 | 0,02% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $343.335 | 9.883 | 0,02% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $335.936 | 9.670 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $332.358 | 9.567 | 0,02% | Aktien |
| Skopos Labs, Inc. | $325.864 | 14.125 | 0,02% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $325.688 | 9.375 | 0,02% | Aktien |
| Brevan Howard Capital Management LP | $306.511 | 8.823 | 0,02% | Aktien |
| KLP KAPITALFORVALTNING AS | $284.868 | 8.200 | 0,02% | Aktien |
Unternehmensinsider 12 Insider · 5 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Zhengbin Yao | President and CEO | 2. Februar 2026 A | — | 0 | 0 | $0 |
| Winston Kung | Chief Financial Officer | 2. Februar 2026 A | — | 0 | 0 | $0 |
| Stuart Lutzker | President of R&D | 2. Februar 2026 A | — | 0 | 0 | $0 |
| Robin Lachapelle | Chief Operating Officer | 2. Februar 2026 A | 135.736 | 0 | 0 | $0 |
| James Paul Kastenmayer | General Counsel | 2. Februar 2026 A | — | 0 | 0 | $0 |
| Merdad Parsey | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Chris Nolet | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| John Hohneker | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Kristine Peterson | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 30. Januar 2024 C | 1.513.664 | 0 | 0 | $0 |
| Dr. James I. Healy | Direktor | 30. Januar 2024 C | 1.696.752 | 0 | 0 | $0 |
| Bahija Jallal | Direktor | 25. Januar 2024 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Limited ×2 Einreichungen | 13. August 2025 | 7,50% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 36 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,94% | 11.300 NS | 30. April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,85% | 45.563 NS | 31. Mai 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,73% | 42.744 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,27% | 128.880 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,24% | 40.097 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 2.536 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 40.649 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,08% | 241.019 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,07% | 341.513 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,06% | 1.527 NS | 31. Mai 2026 | N-PORT |
| SMMV · iShares Trust | 0,06% | 5.272 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 218.131 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,04% | 964.850 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 13.947 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 1.517 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 147.128 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 4.084 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 16.098 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1.457 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 1.187 NS | 31. Mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,01% | 4.450 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 9.868 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 9.849 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 1.200 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 396.954 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 73.260 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 41.476 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 22.839 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.242 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.051 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 30 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 49.423 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18.008 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7.625 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.338.764 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.280 SH | 8. August 2026 | Täglich |